Clinical Evidence

Explore the clinical evidence shaping the probiotics market today

Filter by Wellness Area

Therapeutical Areas to Clinical Evidence (desktop)
  • All
  • Weight Management
  • Gastrointestinal health
  • Pediatric health
  • Oral health
  • Cardiometabolic health
  • Immune health
  • Cognitive health
  • Skin health
  • Women's health
  • Eye health
Therapeutical Areas to Clinical Evidence (mobile)

Filter by Product

Products to Clinical Evidence (desktop)
  • All
  • KABP® Intensive G.I
  • KABP® Urinary Tract Support
  • KABP® Mature Immune Defense®
  • KABP® DENTALAC
  • LipiGO®
  • KABP® Digest
  • Brain (DR7)®
  • DR7
  • KABP® DENTISANI
  • KABP® Baby Colic
  • KABP® Vaginal Health Balance
  • KABP Cardio
  • KABP®-051
  • AB-Protears®
  • Kaneka Probiotics L.sakei proBio65 ®
  • KABP 21®
  • KABP® MENOPAUSE
Products to Clinical Evidence (mobile)
  • Regular consumption of LipiGO® promotes the reduction of body weight and improves the rebound effect of obese people undergo a comprehensive weight loss program

    2020

    Valero-Perez, et al

    Read
  • Polysaccharide-rich hydrolysate from Saccharomyces cerevisiae (LipiGO®) increases fatty acid and neutral sterol excretion in guinea pigs fed with hypercholesterolemic diets

    2017

    Santas J, et al

    Read
  • Effect of a polysaccharide-rich hydrolysate from Saccharomyces cerevisiae (LipiGO®) in body weight loss: randomised, double-blind, placebo-controlled clinical trial in overweight and obese adults

    2017

    Santas J, et al

    Read